BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 27721165)

  • 21. Assessment of singlet oxygen dosimetry concepts in photodynamic therapy through computational modeling.
    Kareliotis G; Liossi S; Makropoulou M
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():224-233. PubMed ID: 29292205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating the impact of oxygen concentration and blood flow variation on photodynamic therapy.
    Penjweini R; Kim MM; Finlay JC; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2016 Feb; 9694():. PubMed ID: 27453622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of the low concentration correction in the macroscopic singlet oxygen model for PDT.
    Kim MM; Penjweini R; Finlay JC; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2015 Mar; 9694():96940D. PubMed ID: 27053824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macroscopic singlet oxygen modeling for dosimetry of Photofrin-mediated photodynamic therapy: an in-vivo study.
    Qiu H; Kim MM; Penjweini R; Zhu TC
    J Biomed Opt; 2016 Aug; 21(8):88002. PubMed ID: 27552311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactive oxygen species explicit dosimetry to predict local tumor growth for Photofrin-mediated photodynamic therapy.
    Sheng T; Ong Y; Busch TM; Zhu TC
    Biomed Opt Express; 2020 Aug; 11(8):4586-4601. PubMed ID: 32923066
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Penjweini R; Kim MM; Ong YH; Zhu TC
    Phys Med Biol; 2020 Jan; 65(3):03LT01. PubMed ID: 31751964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactive oxygen species explicit dosimetry to predict local tumor control for Photofrin-mediated photodynamic therapy.
    Sheng T; Ong YH; Busch TM; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2019 Feb; 10860():. PubMed ID: 31327886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comparison of Singlet Oxygen Explicit Dosimetry (SOED) and Singlet Oxygen Luminescence Dosimetry (SOLD) for Photofrin-Mediated Photodynamic Therapy.
    Kim MM; Penjweini R; Gemmell NR; Veilleux I; McCarthy A; Buller GS; Hadfield RH; Wilson BC; Zhu TC
    Cancers (Basel); 2016 Dec; 8(12):. PubMed ID: 27929427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Singlet oxygen dosimetry modeling for photodynamic therapy.
    Liang X; Wang KK; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2012 Feb; 8210():. PubMed ID: 26005246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.
    James NS; Cheruku RR; Missert JR; Sunar U; Pandey RK
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30042350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
    Liu B; Farrell TJ; Patterson MS
    Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
    Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
    Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive Oxygen Species Explicit Dosimetry (ROSED) of a Type 1 Photosensitizer.
    Ong YH; Kim MM; Huang Z; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2018 Feb; 10476():. PubMed ID: 29861531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of combined Monte Carlo and photokinetic simulations for the outcome correlation analysis of benzoporphyrin derivative-mediated photodynamic therapy on mice.
    Beeson KW; Parilov E; Potasek M; Kim MM; Zhu TC
    J Biomed Opt; 2019 Mar; 24(3):1-9. PubMed ID: 30873764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT.
    Zhu TC; Altschuler MD; Hu Y; Wang K; Finlay JC; Dimofte A; Cengel K; Hahn SM
    Proc SPIE Int Soc Opt Eng; 2010 Jan; 7551():. PubMed ID: 25995533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiological considerations acting on triplet oxygen for explicit dosimetry in photodynamic therapy.
    Sánchez V; Romero MP; Pratavieira S; Costa C
    Photodiagnosis Photodyn Ther; 2017 Sep; 19():298-303. PubMed ID: 28750754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA).
    Aveline B; Hasan T; Redmond RW
    Photochem Photobiol; 1994 Mar; 59(3):328-35. PubMed ID: 8016212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical modification of a tetrapyrrole-type photosensitizer: tuning application and photochemical action beyond the singlet oxygen channel.
    Riyad YM; Naumov S; Schastak S; Griebel J; Kahnt A; Häupl T; Neuhaus J; Abel B; Hermann R
    J Phys Chem B; 2014 Oct; 118(40):11646-58. PubMed ID: 25207950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A feasibility study of singlet oxygen explicit dosmietry (SOED) of PDT by intercomparison with a singlet oxygen luminescence dosimetry (SOLD) system.
    Kim MM; Penjweini R; Gemmell NR; Veilleux I; McCarthy A; Buller G; Hadfield RH; Wilson BC; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2016 Feb; 9694():. PubMed ID: 27064489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photodynamic therapy efficacy enhanced by dynamics: the role of charge transfer and photostability in the selection of photosensitizers.
    Arnaut LG; Pereira MM; Dąbrowski JM; Silva EF; Schaberle FA; Abreu AR; Rocha LB; Barsan MM; Urbańska K; Stochel G; Brett CM
    Chemistry; 2014 Apr; 20(18):5346-57. PubMed ID: 24644142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.